Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded 'No longer looking for participants' as the recruitment status and introduced revision v3.6.0. Removed the prior revision tag v3.5.5 from the history.SummaryDifference0.4%

- Check21 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous revision v3.5.4 was removed. This updates the version history trail without altering the study data or core details.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry was added to the record history, updating the page from version v3.5.3 to v3.5.4. This reflects a minor update in the versioning of the page and does not alter displayed study data.SummaryDifference0.1%

- Check63 days agoChange DetectedA minor change updates the displayed ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3, reflecting a site/version release rather than a change to the study record content.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision entry v3.5.0 was added and the previous v3.4.3 entry removed in the Record History. No substantive content changes are shown.SummaryDifference0.1%

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.